\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Stock Quote

NASDAQCRDF
$5.31
NASDAQCRDF
Open
$5.32
Change
-$0.05 (-0.93%)
Day's Range
$5.10 - $5.52
52-Week Range
$4.29 - $25.50
Volume
956.8K
Market Cap
$199.4M